BB
BigHat Biosciences, Inc.
SEC filingBiotechnology · San Mateo, CA
Amount raised$75.1Msold at filing
Total offering$80M$4.9M still open
Investors in the raise29count reported to the SEC
FiledOct 26, 2026first sale Jul 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Peyton GreensideExecutive Officer, Director
Vineeta AgarwalaDirector
Robert ChessDirector
Francisco GimenezDirector
Andrew ConradDirector
Executive officers, directors and promoters as listed on the Form D.